Cardio Diagnostics, Inc, a biotechnology company making cardiovascular disease prevention and early detection more accessible, personalized and precise, announces the launch of its patent-pending ...
CMS released proposals to update cardiovascular disease risk assessment and risk management services. The organization proposed coding and payment for an atherosclerotic cardiovascular disease risk ...
The 10-year risk estimates for major adverse cardiovascular events underestimate the 20-year cardiovascular burden by nearly three- to tenfold, with the increase in events between 10 and 20 years ...
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company’s clinical blood test, Epi+Gen CHD ...
Researchers from the Johns Hopkins Bloomberg School of Public Health have developed a single "universal risk prediction model" for cardiovascular disease that, in initial tests, works well for ...
Cardio Diagnostics Enters Into an Agreement with AGEPHA Pharma to Advance Precision Assessment and Management of Inflammation Associated with Coronary Heart Disease AGEPHA Pharma will supply LODOCO® ...
What Is the Incremental Value of a Coronary Artery Calcium Score for Cardiovascular Risk Assessment?
Traditional risk assessment for cardiovascular disease (CVD) uses several factors to compile scores to formulate an estimated CVD risk, used by clinicians to advise their patients. Coronary artery ...
Please provide your email address to receive an email when new articles are posted on . Cardiovascular risk assessments used in the general population did not accurately predict risk among men with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback